DDInter917 DDInter122
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin]. Artesunate was granted FDA approval on 26 May 2020.
Indinavir {u} (Compound) resembles {v} (Compound) Alvimopan
Indinavir {u} (Compound) treats {v} (Disease) acquired immunodeficiency syndrome
Indinavir {u} (Compound) binds {v} (Gene) CYP2D6
Indinavir {u} (Compound) upregulates {v} (Gene) SSBP2
Indinavir {u} (Compound) downregulates {v} (Gene) MIF
Indinavir {u} (Compound) causes {v} (Side Effect) Body temperature increased
Indinavir {u} may cause a minor interaction that can limit clinical effects when taken with {v} Medroxyprogesterone acetate
Indinavir {u} may cause a minor interaction that can limit clinical effects when taken with {v} Fluconazole
Indinavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lidocaine
Indinavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aldesleukin
Indinavir (Compound) resembles Alvimopan (Compound)
Indinavir (Compound) treats acquired immunodeficiency syndrome (Disease)
Indinavir (Compound) binds CYP2D6 (Gene)
Indinavir (Compound) upregulates SSBP2 (Gene)
Indinavir (Compound) downregulates MIF (Gene)
Indinavir (Compound) causes Body temperature increased (Side Effect)
Indinavir may cause a minor interaction that can limit clinical effects when taken with Medroxyprogesterone acetate
Indinavir may cause a minor interaction that can limit clinical effects when taken with Fluconazole
Indinavir may cause a moderate interaction that could exacerbate diseases when taken with Lidocaine
Indinavir may cause a moderate interaction that could exacerbate diseases when taken with Aldesleukin